VBS Fellows Foray 2021: Case-Based Examples and Real-World Treatment Strategies - On-demand Webinar

This activity is supported by independent medical education grants from Regeneron Pharmaceuticals and Carl Zeiss Meditec.

Learning Objectives

Upon completion of this activity, the participant should be able to:

• Discuss a wide variety of treatment approaches for common retinal diseases, including age-related macular degeneration and diabetic eye disease.
• Develop individualized treatment plans for patients with retina disorders that use a combination of treat and extend, treat and observe, or pro re nata.
• Apply case study examples to real-world clinical settings.

Accreditation and Designation Statement

Provided by Evolve Medical Education

Accreditation Statement

Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

Evolve designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participation Method

In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

Course Viewing Requirements
Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS

Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+

Faculty and Disclosures

VBS Modertaors:

Anton Orlin, MD
Associate Professor of Ophthalmology
Weill Cornell Medical College
New York, NY

D. Wilkin Parke III, MD
VitreoRetinal Surgery, PA Co-director
Vitreoretinal Surgery Fellowship Program
Minneapolis, MN

Aleksandra V. Rachitskaya, MD
Assistant Professor of Ophthalmology
Cole Eye Institute, Cleveland Clinic
Cleveland, OH

Panelists:

Fellows: 

DISCLOSURE POLICY It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity. The following faculty/staff members have the following financial relationships with commercial interests:

Moderators:

Anton Orlin, MD, has no financial relationships with commercial interests.

D. Wilkin Parke III, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Royalties: Vortex Surgical.

Aleksandra V. Rachitskaya, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Allergan, Carl Zeiss Meditec, Novartis, and Regeneron Pharmaceuticals. Grant/Research Support: Genentech, and Novartis.

Camila Ventura, MD, PhD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Grant/Research Support: NICHD/NIH. Speaker’s Bureau: Novartis.

Panelists:

S.K. Steven Houston III, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, and Optos. Stock/Shareholder: Healtheia.
Jennifer I. Lim, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Cognition, Eyenuk, Genentech, Iveric, Novartis, and Regeneron Pharmaceuticals. Data Monitoring Committee: Aura Bioscience, Ophthea, Quark, and Santen. Grant/Research Support: Allergan, Chengdu Pharma, Genentech, Graybug, Regeneron Pharmaceuticals, and Stealth.
André Maia, MD, PhD has no financial relationships with commercial interests.

Fellows:
Saud ALJohani, MD, Natasha Cruz, MD, Luis C. Escaf, MD, Tahsin Khundkar, MD, Diana M. Laura, MD, Huy Nguyen, MD, Hassan N. Tausif, MD, Adam Weiner, MD have no financial relationships with commercial interests.

Editorial Support Disclosures
The Evolve staff and planners have no financial relationships with commercial interests.  Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.

Disclaimer